Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health.

Beyer K, Zaura E, Brandt BW, Buijs MJ, Brun JG, Crielaard W, Bolstad AI.

PLoS One. 2018 Sep 19;13(9):e0202278. doi: 10.1371/journal.pone.0202278. eCollection 2018.

2.

The effects of a probiotic milk drink on bacterial composition in the supra- and subgingival biofilm: a pilot study.

Becirovic A, Abdi-Dezfuli JF, Hansen MF, Lie SA, Vasstrand EN, Bolstad AI.

Benef Microbes. 2018 Dec 7;9(6):865-874. doi: 10.3920/BM2018.0009. Epub 2018 Jul 25.

PMID:
30041533
3.

Marine ω-3, vitamin D levels, disease outcome and periodontal status in rheumatoid arthritis outpatients.

Beyer K, Lie SA, Kjellevold M, Dahl L, Brun JG, Bolstad AI.

Nutrition. 2018 Nov;55-56:116-124. doi: 10.1016/j.nut.2018.03.054. Epub 2018 Apr 4.

4.

The effect of metronidazole plus amoxicillin or metronidazole plus penicillin V on periodontal pathogens in an in vitro biofilm model.

Dabija-Wolter G, Al-Zubaydi SS, Mohammed MMA, Bakken V, Bolstad AI.

Clin Exp Dent Res. 2018 Jan 2;4(1):6-12. doi: 10.1002/cre2.96. eCollection 2018 Feb.

5.

Cytokine profile in gingival crevicular fluid and plasma of patients with aggressive periodontitis.

Zein Elabdeen HR, Mustafa M, Ali R, Bolstad AI.

Acta Odontol Scand. 2017 Nov;75(8):616-622. doi: 10.1080/00016357.2017.1372623. Epub 2017 Sep 3.

PMID:
28868949
6.

Epidemiology of Sjögren's Syndrome-from an Oral Perspective.

Bolstad AI, Skarstein K.

Curr Oral Health Rep. 2016;3(4):328-336. Epub 2016 Sep 2. Review.

7.

Angiogenic and Immunomodulatory Properties of Endothelial and Mesenchymal Stem Cells.

Bartaula-Brevik S, Pedersen TO, Finne-Wistrand A, Bolstad AI, Mustafa K.

Tissue Eng Part A. 2016 Feb;22(3-4):244-52. doi: 10.1089/ten.TEA.2015.0316. Epub 2016 Jan 19.

8.

Leukocyte transmigration into tissue-engineered constructs is influenced by endothelial cells through Toll-like receptor signaling.

Bartaula-Brevik S, Pedersen TO, Blois AL, Papadakou P, Finne-Wistrand A, Xue Y, Bolstad AI, Mustafa K.

Stem Cell Res Ther. 2014 Dec 20;5(6):143. doi: 10.1186/scrt533.

9.

Subgingival microbial profiles of Sudanese patients with aggressive periodontitis.

Elabdeen HR, Mustafa M, Hasturk H, Klepac-Ceraj V, Ali RW, Paster BJ, Van Dyke T, Bolstad AI.

J Periodontal Res. 2015 Oct;50(5):674-82. doi: 10.1111/jre.12250. Epub 2014 Dec 9.

10.

Reply to 'comment on no association of primary Sjögren's syndrome with Fcγ receptor gene variants'.

Haldorsen K, Bruland O, Appel S, Bolstad AI.

Genes Immun. 2013 Dec;14(8):532. doi: 10.1038/gene.2013.51. Epub 2013 Oct 10. No abstract available.

PMID:
24108103
11.

Ratio of pro-resolving and pro-inflammatory lipid mediator precursors as potential markers for aggressive periodontitis.

Elabdeen HR, Mustafa M, Szklenar M, Rühl R, Ali R, Bolstad AI.

PLoS One. 2013 Aug 12;8(8):e70838. doi: 10.1371/journal.pone.0070838. eCollection 2013.

12.

Role of integrins in the periodontal ligament: organizers and facilitators.

Barczyk M, Bolstad AI, Gullberg D.

Periodontol 2000. 2013 Oct;63(1):29-47. doi: 10.1111/prd.12027. Review.

13.

Co-culture of human bone marrow stromal cells with endothelial cells alters gene expression profiles.

Xue Y, Xing Z, Bolstad AI, Van Dyke TE, Mustafa K.

Int J Artif Organs. 2013 Oct 3;36(9):650-62. doi: 10.5301/ijao.5000229. Epub 2013 Aug 2.

14.

Resolvin D1 protects periodontal ligament.

Mustafa M, Zarrough A, Bolstad AI, Lygre H, Mustafa K, Hasturk H, Serhan C, Kantarci A, Van Dyke TE.

Am J Physiol Cell Physiol. 2013 Sep 15;305(6):C673-9. doi: 10.1152/ajpcell.00242.2012. Epub 2013 Jul 17.

15.

No association of primary Sjögren's syndrome with Fcγ receptor gene variants.

Haldorsen K, Appel S, Le Hellard S, Bruland O, Brun JG, Omdal R, Kristjansdottir G, Theander E, Fernandes CP, Kvarnström M, Eriksson P, Rönnblom L, Herlenius MW, Nordmark G, Jonsson R, Bolstad AI.

Genes Immun. 2013 Jun;14(4):234-7. doi: 10.1038/gene.2013.12. Epub 2013 Apr 4.

PMID:
23552400
16.

α11β1 integrin-mediated MMP-13-dependent collagen lattice contraction by fibroblasts: evidence for integrin-coordinated collagen proteolysis.

Barczyk MM, Lu N, Popova SN, Bolstad AI, Gullberg D.

J Cell Physiol. 2013 May;228(5):1108-19. doi: 10.1002/jcp.24261.

PMID:
23065814
17.

Gingival lymphatic drainage protects against Porphyromonas gingivalis-induced bone loss in mice.

Mkonyi LE, Bletsa A, Bolstad AI, Bakken V, Wiig H, Berggreen E.

Am J Pathol. 2012 Sep;181(3):907-16. doi: 10.1016/j.ajpath.2012.05.027.

PMID:
22901755
18.

Use of siRNA in dental tissue-derived cell cultures: integrin knockdown in fibroblasts.

Barczyk MM, Gullberg D, Bolstad AI.

Methods Mol Biol. 2012;887:49-57. doi: 10.1007/978-1-61779-860-3_6.

PMID:
22566046
19.

Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples.

Bolstad AI, Le Hellard S, Kristjansdottir G, Vasaitis L, Kvarnström M, Sjöwall C, Johnsen SJ, Eriksson P, Omdal R, Brun JG, Wahren-Herlenius M, Theander E, Syvänen AC, Rönnblom L, Nordmark G, Jonsson R.

Ann Rheum Dis. 2012 Jun;71(6):981-8. doi: 10.1136/annrheumdis-2011-200446. Epub 2012 Jan 30.

PMID:
22294627
20.

Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.

Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A, Kelly JA, Mavragani CP, Gatumu M, Skarstein K, Browning JL.

Arthritis Res Ther. 2011;13(6):R182. doi: 10.1186/ar3507. Epub 2011 Nov 1.

21.

A five-year prospective study of fatigue in primary Sjögren's syndrome.

Haldorsen K, Bjelland I, Bolstad AI, Jonsson R, Brun JG.

Arthritis Res Ther. 2011;13(5):R167. doi: 10.1186/ar3487. Epub 2011 Oct 13.

22.

Global gene expression profile of osteoblast-like cells grown on polyester copolymer scaffolds.

Idris SB, Bolstad AI, Ibrahim SO, Dånmark S, Finne-Wistrand A, Albertsson AC, Arvidson K, Mustafa K.

Tissue Eng Part A. 2011 Nov;17(21-22):2817-31. doi: 10.1089/ten.tea.2010.0660. Epub 2011 Sep 9.

PMID:
21905880
23.

Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases.

Anaya JM, Kim-Howard X, Prahalad S, Cherñavsky A, Cañas C, Rojas-Villarraga A, Bohnsack J, Jonsson R, Bolstad AI, Brun JG, Cobb B, Moser KL, James JA, Harley JB, Nath SK.

Autoimmun Rev. 2012 Feb;11(4):276-80. doi: 10.1016/j.autrev.2011.07.007. Epub 2011 Aug 5. Review.

24.

LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.

Fava RA, Browning JL, Gatumu M, Skarstein K, Bolstad AI.

Adv Exp Med Biol. 2011;691:383-90. doi: 10.1007/978-1-4419-6612-4_39. No abstract available.

PMID:
21153342
25.

Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome.

Cobb BL, Fei Y, Jonsson R, Bolstad AI, Brun JG, Rischmueller M, Lester SE, Witte T, Illei G, Brennan M, Bowman S, Moser KL, Harley JB, Sawalha AH.

Ann Rheum Dis. 2010 Sep;69(9):1731-2. doi: 10.1136/ard.2009.122903. Epub 2010 Mar 9. No abstract available.

26.

Polyester copolymer scaffolds enhance expression of bone markers in osteoblast-like cells.

Idris SB, Arvidson K, Plikk P, Ibrahim S, Finne-Wistrand A, Albertsson AC, Bolstad AI, Mustafa K.

J Biomed Mater Res A. 2010 Aug;94(2):631-9. doi: 10.1002/jbm.a.32726.

PMID:
20205238
27.

A role for alpha11beta1 integrin in the human periodontal ligament.

Barczyk MM, Olsen LH, da Franca P, Loos BG, Mustafa K, Gullberg D, Bolstad AI.

J Dent Res. 2009 Jul;88(7):621-6. doi: 10.1177/0022034509339291.

PMID:
19641149
28.

The minor salivary gland proteome in Sjögren's syndrome.

Hjelmervik TO, Jonsson R, Bolstad AI.

Oral Dis. 2009 Jul;15(5):342-53. doi: 10.1111/j.1601-0825.2009.01531.x. Epub 2009 Apr 2.

PMID:
19364392
29.

Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.

Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI.

Arthritis Res Ther. 2009;11(1):R24. doi: 10.1186/ar2617. Epub 2009 Feb 18.

30.

The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice.

Hjelmervik TO, Lindqvist AK, Petersen K, Johannesson M, Stavrum AK, Johansson A, Jonsson R, Holmdahl R, Bolstad AI.

Arthritis Res Ther. 2007;9(5):R99.

31.

Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.

Jonsson R, Bolstad AI, Brokstad KA, Brun JG.

Ann N Y Acad Sci. 2007 Jun;1108:433-47. Review.

PMID:
17894008
32.

Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool.

Centola M, Frank MB, Bolstad AI, Alex P, Szanto A, Zeher M, Hjelmervik TO, Jonsson R, Nakken B, Szegedi G, Szodoray P.

Scand J Immunol. 2006 Sep;64(3):236-42. Review.

33.

Gene therapeutics in Sjögren's syndrome.

Bolstad AI, Jonsson R.

Expert Opin Biol Ther. 2005 Jun;5(6):763-72. Review.

PMID:
15952907
34.

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI.

Arthritis Rheum. 2005 May;52(5):1534-44.

35.

Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands.

Entesarian M, Matsson H, Klar J, Bergendal B, Olson L, Arakaki R, Hayashi Y, Ohuchi H, Falahat B, Bolstad AI, Jonsson R, Wahren-Herlenius M, Dahl N.

Nat Genet. 2005 Feb;37(2):125-7. Epub 2005 Jan 16.

PMID:
15654336
36.

Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.

Harangi M, Kaminski WE, Fleck M, Orsó E, Zeher M, Kiss E, Szekanecz Z, Zilahi E, Marienhagen J, Aslanidis C, Paragh G, Bolstad AI, Jonsson R, Schmitz G.

Eur J Immunol. 2005 Jan;35(1):305-17.

37.
38.

Genetic aspects of Sjögren's syndrome.

Bolstad AI, Jonsson R.

Arthritis Res. 2002;4(6):353-9. Epub 2002 Sep 24. Review.

39.

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gröndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME.

Nat Genet. 2002 Dec;32(4):666-9. Epub 2002 Oct 28.

PMID:
12402038
40.

Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.

Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA.

Autoimmunity. 2001;34(2):123-32. Review.

PMID:
11905842
41.

The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross.

Johansson AC, Nakken B, Sundler M, Lindqvist AK, Johannesson M, Alarcón-Riquelme M, Bolstad AI, Humphreys-Beher MG, Jonsson R, Skarstein K, Holmdahl R.

Eur J Immunol. 2002 Jan;32(1):243-50.

42.

The role of apoptosis in Sjögren's syndrome.

Bolstad AI, Jonsson R.

Ann Med Interne (Paris). 1998 Feb;149(1):25-9. Review.

PMID:
11490513
43.

HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome.

Bolstad AI, Wassmuth R, Haga HJ, Jonsson R.

J Rheumatol. 2001 Jul;28(7):1554-62.

PMID:
11469461
44.

Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome.

Magnusson V, Nakken B, Bolstad AI, Alarcón-Riquelme ME.

Scand J Immunol. 2001 Jul-Aug;54(1-2):55-61. Review. Erratum in: Scand J Immunol 2001 Dec;54(6):642.

45.

Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes.

Johansson AC, Sundler M, Kjellén P, Johannesson M, Cook A, Lindqvist AK, Nakken B, Bolstad AI, Jonsson R, Alarcón-Riquelme M, Holmdahl R.

Eur J Immunol. 2001 Jun;31(6):1847-56.

46.
47.

Fas-induced apoptosis is a rare event in Sjögren's syndrome.

Ohlsson M, Skarstein K, Bolstad AI, Johannessen AC, Jonsson R.

Lab Invest. 2001 Jan;81(1):95-105.

48.

Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.

Magnusson V, Lindqvist AK, Castillejo-López C, Kristjánsdottir H, Steinsson K, Gröndal G, Sturfelt G, Truedsson L, Svenungsson E, Lundberg I, Gunnarsson I, Bolstad AI, Haga HJ, Jonsson R, Klareskog L, Alcocer-Varela J, Alarcón-Segovia D, Terwilliger JD, Gyllensten UB, Alarcón-Riquelme ME.

Genomics. 2000 Dec 15;70(3):307-14.

PMID:
11161781
49.

Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.

Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R.

J Rheumatol. 2000 Oct;27(10):2397-405.

PMID:
11036836
50.

Monozygotic twins with primary Sjögren's syndrome.

Bolstad AI, Haga HJ, Wassmuth R, Jonsson R.

J Rheumatol. 2000 Sep;27(9):2264-6.

PMID:
10990245

Supplemental Content

Loading ...
Support Center